Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2023-02-07 Board/Management Inform…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Dividend
Board/Management Information Classification · 95% confidence The document is a letter dated 7th February 2023 from the Company Secretary of Sanofi India Limited addressed to stock exchanges. It announces a forthcoming Board of Directors meeting scheduled for 23rd February 2023 to consider approving audited accounts for the quarter and year ended 31st December 2022 and to recommend dividends. The letter also mentions the closure of the trading window for designated persons. The document is an announcement of a board meeting and related agenda items, not the actual financial report or results. It is short (1994 characters) and serves as a notification rather than a report or detailed filing. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board meetings and related management information.
2023-02-07 English
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2023 ,inter alia, to consider and approve 1) the audited accounts for the ....
Board/Management Information Classification · 95% confidence The document is a letter dated 7th February 2023 from the Company Secretary of Sanofi India Limited addressed to stock exchanges. It announces a forthcoming Board of Directors meeting scheduled for 23rd February 2023 to consider approving audited accounts for the quarter and year ended 31st December 2022 and to recommend dividends. The document also mentions the closure of the trading window for designated persons. The content is an announcement of a future board meeting and financial results approval, not the financial report itself. The document length is short (1994 characters) and does not contain actual financial data or detailed financial statements. Therefore, it is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is also not a certification or voting result. The document fits best as a Board/Management Information (MANG) filing, as it relates to board meeting scheduling and related disclosures under SEBI regulations.
2023-02-07 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss reporting. The content is a notification of a specific event (loss of share certificates) and does not contain financial data, management discussion, or any report. It is not an annual report, earnings release, or any financial statement. It is also not a voting result, director dealing, or capital change announcement. The document is a regulatory compliance notification to stock exchanges about share certificate loss, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2023-02-06 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates, referencing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015. It provides details of the lost certificates and requests the information be taken on record. The document is short (1522 characters) and does not contain financial data, management discussion, or report content. It is an official regulatory announcement related to share certificate loss, which does not fit into financial reports or other specific categories. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-02-06 English
Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. Makarand M. Joshi & Co., Company Secretaries ....
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended 31st December 2022. It is a compliance certificate from a company secretary firm regarding share transfer processes and timelines. The document is short (3269 characters) and primarily serves as a certification letter rather than a full financial or operational report. It does not contain financial statements, management discussion, or detailed report content. It is not an announcement of a report but a regulatory compliance certificate. According to the rules, such officer certifications or attestations fall under Regulatory Filings (RNS).
2023-01-27 English
As required under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming the maintenance of share transfer facilities for the year ended 31st December 2022. It is signed by the Company Secretary and Compliance Officer and the Registrar & Share Transfer Agent. The document is short (2877 characters) and serves as a certification or confirmation letter rather than a detailed financial report or announcement. It does not contain financial statements or substantive financial data. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and not a full report or announcement of a report.
2023-01-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.